Unlike ovarian, breast, pancreatic, and prostate cancer, melanoma has a much lower frequency of BRCA1 and BRCA2 mutations, and there is little evidence of its contribution to melanoma pathogenesis (20). The gene discussed is BRCA1; the disease is Familial prostate cancer.